Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Voxel-level biological optimisation of prostate IMRT using patient-specific tumour location and clonogen density derived from mpMRI

Her EJ, Haworth A, Reynolds HM, Sun Y, Kennedy A, Panettieri V, Bangert M, Williams S, Ebert MA

(2020), Radiat Oncol, 15(1), 172

DOI: 10.1186/s13014-020-01568-6

Total body irradiation in Australia and New Zealand: results of a practice survey

Fog LS, Wirth A, MacManus M, Downes S, Grace M, Moggré A, Mugabe K, Neveri G, Nourbehesht L, Panettieri V, Pope D, Sim L, Stanton C, Steer B, Stewart A, Ungureanu E, Kron T

(2020), Physical and Engineering Sciences in Medicine, 43(3), 825-35

DOI: 10.1007/s13246-020-00878-z

Samarium doped titanium dioxide nanoparticles as theranostic agents in radiation therapy

Nakayama M, Smith CL, Feltis BN, Piva TJ, Tabatabaie F, Harty PD, Gagliardi FM, Platts K, Otto S, Blencowe A, Morita K, Geso M

(2020), PHYS MEDICA, 75, 69-76

DOI: 10.1016/j.ejmp.2020.06.007

A biochemical definition of cure after brachytherapy for prostate cancer

Crook JM, Tang C, Thames H, Blanchard P, Sanders J, Ciezki J, Keyes M, Morris WJ, Merrick G, Catton C, Raziee H, Stock R, Sullivan F, Anscher M, Millar J, Frank S

(2020), Radiother Oncol, 149, 64-9

DOI: 10.1016/j.radonc.2020.04.038

The Australian and New Zealand Thyroid Cancer Registry Annual Report, 2019

Ioannou L, Serpell J, Greenhill E, Bavor C, Hansen J, Earnest A, Miller J, Bendinelli C, Cope D, Glover A, Gough J, Harper S, Lee J, Lisewski D, Meyer-Rochow W, Millar J, Sidhu S, Sywak M, Topliss D, Walters D, Zalcberg J, Allnutt M, Bhatt C, Ahern S

(2020), Public Health and Preventive Medicine, Monash University, June 2020, Report No. 02.,

Are We Choosing Wisely in Radiation Oncology Practice–Findings From an Australian Population-Based Study

Ong, Wee Loon; Foroudi, Farshad; Milne, Roger L.; Millar, Jeremy L.

(2019), INT J RADIAT ONCOL, 104(5), 1012-1016.

DOI: 10.1016/j.ijrobp.2019.03.048

Quality of Life Outcomes After Stereotactic Ablative Radiation Therapy (SABR) Versus Standard of Care Treatments in the Oligometastatic Setting

Olson, Robert; Senan, Suresh; Harrow, Stephen; Gaede, Stewart; Louie, Alexander; Haasbeek, Cornelis; Mulroy, Liam; Lock, Michael; Rodrigues, George; Yaremko, Brian; Schellenberg, Devin; Ahmad, Belal; Griffioen, Gwendolyn; Senthi, Sashendra; Swaminath, Anand; Kopek, Neil; Liu, Mitchell; Moore, Karen; Currie, Suzanne; Bauman, Glenn; Warner, Andrew; Palma, David

(2019), INT J RADIAT ONCOL, 105(5), 943-947.

DOI: 10.1016/j.ijrobp.2019.08.041

Contrast enhanced oesophageal avoidance for stereotactic body radiotherapy: Barium vs. Gastrografin

Woodford K, Panettieri V, Ruben JD, Davis S, Sim E, Tran Le T, Senthi S

(2019), Tech Innov Patient Support Radiat Oncol, 12, 16-22

DOI: 10.1016/j.tipsro.2019.10.004

Stereotactic ablative radiotherapy for the comprehensive treatment of 4-10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial

Palma DA, Olson R, Harrow S, Correa RJM, Schneiders F, Haasbeek CJA, Rodrigues GB, Lock M, Yaremko BP, Bauman GS, Ahmad B, Schellenberg D, Liu M, Gaede S, Laba J, Mulroy L, Senthi S, Louie AV, Swaminath A, Chalmers A, Warner A, Slotman BJ, de Gruijl TD, Allan A, Senan S

(2019), BMC Cancer, 19(1), 816

DOI: 10.1186/s12885-019-5977-6

Identifying optimal clinical scenarios for synchrotron microbeam radiation therapy: A treatment planning study

Smyth LML, Day LR, Woodford K, Rogers PAW, Crosbie JC, Senthi S

(2019), PHYS MEDICA, 60, 111-9

DOI: 10.1016/j.ejmp.2019.03.019

Long-term treatment outcomes of patients with primary optic nerve sheath meningioma treated with stereotactic radiotherapy

Ratnayake G, Oh T, Mehta R, Hardy T, Woodford K, Haward R, Ruben JD, Dally MJ

(2019), J Clin Neurosci, 68, 162-7

DOI: 10.1016/j.jocn.2019.07.005

Body size and dietary risk factors for aggressive prostate cancer: a case-control study

Pal M, Hodge AM, Papa N, MacInnis RJ, Bassett JK, Bolton D, Davis ID, Millar J, English DR, Hopper JL, Severi G, Southey MC, Milne RL, Giles GG

(2019), CANCER CAUSE CONTROL, 30(12), 1301-12

DOI: 10.1007/s10552-019-01234-7

Contemporary practice patterns of stereotactic radiosurgery for brain metastasis: A review of published Australian literature

Ong WL, Wada M, Ruben J, Foroudi F, Millar J

(2019), J MED IMAG RADIAT ON, 63(5), 711-20

DOI: 10.1111/1754-9485.12942

Forecasting annual incidence and mortality rate for prostate cancer in Australia until 2022 using autoregressive integrated moving average (ARIMA) models

Earnest A, Evans SM, Sampurno F, Millar J

(2019), BMJ Open, 9(8), e031331

DOI: 10.1136/bmjopen-2019-031331

Development of a muticentre automated model to reduce planning variability in radiotherapy of prostate cancer

Panettieri V, Ball D, Chapman A, Cristofaro N, Gawthrop J, Griffin P, Herath S, Howly S, Jukes L, Kron T, Markham C, Marr L, Moloney P, Nelli F, Ramachandran P, Smith A, Hornby CJ

(2019), Phys Imaging Radiat Oncol, 11, 39-40

Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial

Palma DA, Olson R, Harrow S, Gaede S, Louie AV, Haasbeek C, Mulroy L, Lock M, Rodrigues GB, Yaremko BP, Schellenberg D, Ahmad B, Griffioen G, Senthi S, Swaminath A, Kopek N, Liu M, Moore K, Currie S, Bauman GS, Warner A, Senan S

(2019), Lancet, 393(10185), 2051-8

DOI: 10.1016/S0140-6736(18)32487-5

Extent and predictors of grade upgrading and downgrading in an Australian cohort according to the new prostate cancer grade groupings

Beckmann K, O'Callaghan M, Vincent A, Cohen P, Borg M, Roder D, Evans S, Millar J, Moretti K

(2019), Asian J Urol, 6(4), 321-9

DOI: 10.1016/j.ajur.2019.03.001

Development of Technologic Solutions to Address Complex Local Requirements of an International Prostate Cancer Clinical Quality Registry

Sampurno F, Kannan A, Lucas M, Liman J, Connor SE, Pearman E, Millar JL, Moore CM, Villanti P, James E, Huland H, Litwin MS, Evans SM

(2019), JCO Clin Can Inform, 3, 1-11

DOI: 10.1200/CCI.18.00114

Improved survival for patients with prostate cancer receiving high-dose-rate brachytherapy boost to EBRT compared with EBRT alone

Kent AR, Matheson B, Millar JL

(2019), Brachytherapy, 18(3), 313-21

DOI: 10.1016/j.brachy.2019.01.013

A Prospective, Multicenter Study of Involved-Field Radiation Therapy With Autologous Stem Cell Transplantation for Patients With Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphoma (ALLG HDNHL04/TROG 03.03)

Wirth A, Prince HM, Roos D, Gibson J, O'Brien P, Zannino D, Khodr B, Stone JM, Davis S, Hertzberg M

(2019), INT J RADIAT ONCOL, 103(5), 1158-66

DOI: 10.1016/j.ijrobp.2018.12.006

3 4 5 6 7